Collegium Pharmaceutical, Inc(NASDAQ:COLL) 
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta ER and Nucynta IR, which are extended-release and immedia...
Website: http://www.collegiumpharma.com
Founded: 2002
Full Time Employees: 255
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 28.15
H 28.34
L 27.69
C 28.14
V 384,608
10EMA 28.14
20EMA 28.14
60EMA 28.14
120EMA 28.14
250EMA 28.14